We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$29.2M
Cap. Flow
+$27.6M
Cap. Flow %
13.39%
Top 10 Hldgs %
88.47%
Holding
181
New
37
Increased
23
Reduced
71
Closed
16

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$27.6M
2
BKLN icon
Invesco Senior Loan ETF
BKLN
+$319K
3
EMHY icon
iShares JPMorgan EM High Yield Bond ETF
EMHY
+$309K
4
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$249K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$228K

Top Sells

Rank Stock Value
1
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$2.55M
2
NNDM
Nano Dimension
NNDM
+$330K
3
BTAI icon
BioXcel Therapeutics
BTAI
+$235K
4
NUAN
Nuance Communications, Inc.
NUAN
+$145K
5
KTOS icon
Kratos Defense & Security Solutions
KTOS
+$92.4K

Sector Composition

Rank Sector Weight
1 Real Estate 17.29%
2 Healthcare 5.02%
3 Technology 2.17%
4 Industrials 1.56%
5 Financials 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCUS icon
101
Arcus Biosciences
RCUS
$3.44B
$53K 0.03%
3,100
+2,000
+182% +$44.7K
WMT icon
102
Walmart Inc
WMT
$909B
$53K 0.03%
1,128
-102
-8% -$4.54K
AKAM icon
103
Akamai
AKAM
$17.5B
$52K 0.03%
470
-44
-9% -$4.88K
CLDX icon
104
Celldex Therapeutics
CLDX
$2.77B
$52K 0.03%
+3,500
New +$41K
BPMC
105
DELISTED
Blueprint Medicines
BPMC
$51K 0.02%
+550
New +$42.4K
COLL icon
106
Collegium Pharmaceutical
COLL
$1.17B
$50K 0.02%
2,400
-750
-24% -$13.5K
JAZZ icon
107
Jazz Pharmaceuticals
JAZZ
$15.5B
$50K 0.02%
350
-275
-44% -$34.1K
EWM icon
108
iShares MSCI Malaysia ETF
EWM
$311M
$48K 0.02%
+1,823
New +$48.8K
CPB icon
109
Campbell Soup
CPB
$6.58B
$47K 0.02%
972
-84
-8% -$4.15K
EQR icon
110
Equity Residential
EQR
$25.9B
$47K 0.02%
912
-65
-7% -$3.6K
LLY icon
111
Eli Lilly
LLY
$1.05T
$47K 0.02%
316
-28
-8% -$4.33K
MRK icon
112
Merck
MRK
$315B
$46K 0.02%
576
-105
-15% -$8.22K
FUSN
113
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$46K 0.02%
3,800
+2,000
+111% +$27.3K
CTXS
114
DELISTED
Citrix Systems Inc
CTXS
$45K 0.02%
324
-30
-8% -$4.29K
HZNP
115
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$45K 0.02%
575
-150
-21% -$10.3K
ADVM
116
DELISTED
Adverum Biotechnologies
ADVM
$43K 0.02%
+420
New +$62.9K
BMY icon
117
Bristol-Myers Squibb
BMY
$124B
$43K 0.02%
710
– –
VIE
118
DELISTED
Viela Bio, Inc. Common Stock
VIE
$42K 0.02%
+1,500
New +$53.1K
PML
119
PIMCO Municipal Income Fund II
PML
$501M
$41K 0.02%
3,000
– –
IVA
120
Inventiva
IVA
$1.09B
$40K 0.02%
+3,400
New +$39K
TAK icon
121
Takeda Pharmaceutical
TAK
$54.8B
$39K 0.02%
2,200
– –
TCRR
122
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$39K 0.02%
+1,900
New +$33.4K
IOVA icon
123
Iovance Biotherapeutics
IOVA
$2.23B
$38K 0.02%
1,150
– –
ABBV icon
124
AbbVie
ABBV
$450B
$37K 0.02%
425
– –
PAND
125
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
$36K 0.02%
+3,100
New +$53K
3 4
5
6 7

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, AlphaCentric Advisors held 181 positions worth $207M, up 16% from $177M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

AlphaCentric Advisors deployed $27.6M of net new capital in Q3 2020, opening 37 new positions and adding to 23 existing holdings. Its largest new stake was iShares JPMorgan EM High Yield Bond ETF: 6,992 shares worth $305K.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $2.55M trimmed.

  • AlphaCentric Advisors's largest Q3 2020 buy was iShares JPMorgan EM High Yield Bond ETF: 6,992 shares worth $305K.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q3 2020, an estimated $27.6M increase.
  • AlphaCentric Advisors's biggest Q3 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $2.55M.
  • AlphaCentric Advisors fully exited Nano Dimension in Q3 2020, selling an estimated $330K.
  • AlphaCentric Advisors's ten largest holdings make up 88% of its $207M portfolio in Q3 2020.
  • AlphaCentric Advisors opened 37 new positions and closed 16 in Q3 2020.
  • AlphaCentric Advisors's portfolio value rose 16% quarter-over-quarter to $207M.

Based on AlphaCentric Advisors's 13F filing for Q3 2020, filed 11 Mar 2022.